
CNMD
NYEConmed Corp. - Ordinary Shares
Healthcare•Medical Devices
Watchlists:
Last updated: Friday 18th July 2025
49.25
-0.69 (-1.38%)
Prev Close:49.94
Open:49.64
Bid:47.67
Ask:68.08
52 Week Range
46.0078.19
Volume:408,379
Mkt Cap:1,510 M
65
MarketXLS Rank ®
Buy
Price Target
$56.64
+15.0%
Financial Statements
CNMD - Income Statement (Annual)
Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
---|---|---|---|---|---|---|---|---|---|---|
Commission Expenses | -8 M | |||||||||
Fees | 3 M | |||||||||
Gain On Sale Of PPE | -5 M | 2 M | ||||||||
General And Administrative Expense | 478 M | 503 M | 454 M | 415 M | 374 M | 400 M | -9 M | -6 M | -6 M | -5 M |
Gross Profit Margin (profit Margin After CGS) | 733 M | 676 M | 571 M | 568 M | 460 M | 525 M | 469 M | 431 M | 408 M | 382 M |
Impairment Of Capital Assets | 1 M | 2 M | 2 M | 3 M | 5 M | 5 M | -5 M | -4 M | ||
Interest Expense Non Operating | 37 M | 40 M | 29 M | 35 M | 44 M | 43 M | 21 M | 18 M | 15 M | 6 M |
Marketing Expense | 65 M | 61 M | ||||||||
Misc Other Special Charges | 14 M | 13 M | -112 M | -1 M | -355000.0 | -5 M | 5 M | 5 M | -3 M | |
Net Income (loss) | 132 M | 64 M | -81 M | 63 M | 10 M | 29 M | 41 M | 55 M | 15 M | 30 M |
Net Income Common Stockholders | 132 M | 64 M | -81 M | 63 M | 10 M | 29 M | 41 M | 55 M | 15 M | 30 M |
Net Income Continuous Operations | 132 M | 64 M | -81 M | 63 M | 10 M | 29 M | 41 M | 55 M | 15 M | 30 M |
Net Non Operating Interest Income Expense | -37 M | -40 M | -29 M | -35 M | -44 M | -43 M | -21 M | -18 M | -15 M | -6 M |
Non Recurring Operation Expense | -5 M | -4 M | ||||||||
Normalized Income | 122 M | |||||||||
Operating Income | 200 M | 121 M | 70 M | 110 M | 46 M | 79 M | 71 M | 47 M | 38 M | 51 M |
Operating Income Before Depreciation (EBITDA) | 278 M | 199 M | 32 M | 179 M | 118 M | 158 M | 10 M | 105 M | 90 M | 95 M |
Operating Expense | 533 M | 556 M | 501 M | 458 M | 414 M | 446 M | -398 M | -384 M | -371 M | -331 M |
Other Gand A | 478 M | 503 M | 454 M | 415 M | 374 M | 400 M | -9 M | -6 M | -6 M | -5 M |
Other Impairment Of Capital Assets | 606000.0 | 312000.0 | ||||||||
Other Operating Expenses | 10 M | 9 M | 8 M | -2 M | -1 M | -2 M | -2 M | |||
Other Write Down | 3 M | 899000.0 | ||||||||
Rent And Landing Fees | -9 M | -6 M | -6 M | -5 M | ||||||
Research Expense | 54 M | 53 M | 47 M | 44 M | 40 M | 45 M | 42 M | 32 M | 32 M | 27 M |
Restructring And Mn A Income | -44 M | -10 M | -100000.0 | -10 M | -22 M | |||||
Salaries And Wages | -4 M | -4 M | -4 M | -4 M | -3 M | -3 M | -10 M | -8 M | -8 M | -7 M |
Selling And Marketing Expense | 65 M | 61 M | 356 M | 352 M | 338 M | 303 M | ||||
Selling Expense | 356 M | 352 M | 338 M | 303 M | ||||||
Total Income Available For Interest Expense (EBIT) | 200 M | 121 M | -42 M | 109 M | 46 M | 74 M | 71 M | 47 M | 35 M | 51 M |
Total Revenues | 1,307 M | 1,245 M | 1,045 M | 1,011 M | 862 M | 955 M | 860 M | 796 M | 764 M | 719 M |
Total Expenses | 1,107 M | 1,124 M | 975 M | 901 M | 816 M | 876 M | -788 M | -749 M | -726 M | -668 M |
Total Revenue | 1,307 M | 1,245 M | 1,045 M | 1,011 M | 862 M | 955 M | 860 M | 796 M | 764 M | 719 M |
Amord | 807 M | 807 M | 815 M | 618 M | 618 M | 618 M | -23 M | -18 M | -17 M | -13 M |
Avgshs | 31 M | 31 M | 30 M | 29 M | 29 M | 28 M | 28 M | 28 M | 28 M | 28 M |
Avgshsdt | 31 M | 32 M | 30 M | 32 M | 29 M | 29 M | 29 M | 28 M | 28 M | 28 M |
Basiceps | 4.29 | 2.1 | -2.68 | 2.14 | 0.33 | 1.01 | 1.45 | 1.99 | 0.53 | 1.1 |
Basicepscont | 4.29 | 2.1 | -2.68 | 2.14 | 0.33 | 1.01 | ||||
Cor | 574 M | 568 M | 474 M | 443 M | 402 M | 430 M | -391 M | -365 M | -355 M | -337 M |
Dileps | 4.25 | 2.04 | -2.68 | 1.94 | 0.32 | 0.97 | 1.41 | 1.97 | 0.52 | 1.09 |
Dilepscont | 4.25 | 2.04 | -2.68 | 1.94 | 0.32 | 0.97 | ||||
Div Per Share | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Netincdisc | 132 M | 64 M | -81 M | 63 M | 10 M | 29 M | 41 M | 55 M | 15 M | 30 M |
Othincexp | -54 M | -15 M | -112 M | 1 M | 355000.0 | 5 M | -904 M | -5 M | 3 M | |
Pretaxinc | 163 M | 81 M | -71 M | 73 M | 2 M | 31 M | 51 M | 29 M | 19 M | 45 M |
Resdev | 54 M | 53 M | 47 M | 44 M | 40 M | 45 M | 42 M | 32 M | 32 M | 27 M |
Restruct | -44 M | -10 M | -100000.0 | -10 M | -22 M | |||||
Sga | 478 M | 503 M | 454 M | 415 M | 374 M | 400 M | 356 M | 352 M | 338 M | 303 M |
Shsout | 31 M | 31 M | 31 M | 29 M | 29 M | 28 M | 28 M | 28 M | 28 M | 28 M |
Specincchg | -1 M | -2 M | -2 M | -3 M | -5 M | 40 M | 15 M | 10 M | 14 M | 22 M |
Taxprov | 31 M | 16 M | 10 M | 11 M | -8 M | 3 M | 10 M | -27 M | 5 M | 15 M |